Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Keunchil Park, MD, PhD
lungcanc
Dr. Benjamin Levy, MD
lungcanc
Keith Kerr, BSc, MB ChB, FRCPath, FRCPE
lungcanc
Roy S. Herbst, MD, PhD
lungcanc
Peter Hammerman, MD, PhD
lungcanc
FDA Corner – Interview with Amy Mckee, MD
lungcanc
PD-L1 Blueprint Project
lungcanc
Welcome to Year Two of the IASLC Lung Cancer News
lungcanc
Drug Development in the 21st Century
lungcanc
Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A New...
lungcanc
1
...
41
42
43
...
53
Page 42 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
